FNY Investment Advisers »

Atrium Therapeutics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Atrium Therapeutics shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 152 0.00

More positions owned by FNY Investment Advisers

Global X Fds global x copper (COPX)
Codere Online Luxembourg Ord (CDRO)
Sealed Air (SEE)
Clearw.a.hld. (CWAN)
Fonar Corporation (FONR)
Wix (WIX)
Deere & Company (DE)
Amicus Therapeutics (FOLD)
Futurecrest Acquisition Corp (FCRS.U)
Seabridge Gold (SA)
Cme (CME)
Norfolk Southern (NSC)
Willow Lane Acquisition Corp (WLAC)
Terns Pharmaceuticals (TERN)
Astrazeneca Plc Ord (AZN)

View all positions for FNY Investment Advisers

Top funds holding Atrium Therapeutics

Fractal Investments
GAMMA Investing
FNY Investment Advisers
Massmutual Trust
True Wealth Design

View all funds holding Atrium Therapeutics